Contineum Therapeutics, Inc. (CTNM)
NASDAQ: CTNM · Real-Time Price · USD
3.765
-0.115 (-2.96%)
At close: Jul 7, 2025, 4:00 PM
3.810
+0.045 (1.20%)
After-hours: Jul 7, 2025, 6:15 PM EDT
Contineum Therapeutics Market Cap
Contineum Therapeutics has a market cap or net worth of $97.41 million as of July 7, 2025. Its market cap has decreased by -80.12% in one year.
Market Cap
97.41M
Enterprise Value
-86.14M
1-Year Change
-80.12%
Ranking
Category
Stock Price
3.77
Market Cap Chart
Since the IPO on April 5, 2024, Contineum Therapeutics's market cap has decreased from $402.09M to $97.41M, a decrease of -75.78%. That is a compound annual growth rate of -67.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 7, 2025 | 98.57M | -73.90% |
| Dec 31, 2024 | 377.64M | -6.08% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 700.84B |
| Johnson & Johnson | 375.37B |
| AbbVie | 334.34B |
| Novo Nordisk | 316.33B |
| UnitedHealth Group | 279.90B |
| Novartis AG | 242.35B |
| Abbott Laboratories | 233.90B |
| AstraZeneca | 218.65B |